• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双模态氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在复发性碘阴性分化型甲状腺癌患者随访中的应用

Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer.

作者信息

Freudenberg Lutz S, Frilling Andrea, Kühl Hilmar, Müller Stefan P, Jentzen Walter, Bockisch Andreas, Antoch Gerald

机构信息

Department of Nuclear Medicine, University of Duisburg/Essen, Hufelandstrasse 55, 45122, Essen, Germany.

出版信息

Eur Radiol. 2007 Dec;17(12):3139-47. doi: 10.1007/s00330-007-0682-2. Epub 2007 May 22.

DOI:10.1007/s00330-007-0682-2
PMID:18004607
Abstract

The usefulness of combined 2-[18F] fluoro-2-deoxy-D: -glucose positron emission tomography and computed tomography (FDG-PET/CT) in locating suspected recurrence in patients with iodine-negative differentiated thyroid cancer (DTC) was evaluated. Thirty-six patients with DTC and suspected iodine-negative recurrence underwent restaging with FDG-PET/CT. The images of CT, FDG-PET, both modalities viewed side by side (CT+PET), and FDG-PET/CT were evaluated by two physicians separately. Imaging results were correlated with either histology (n = 20) and/or clinical follow-up of at least 36 months. Recurrent disease was diagnosed in 22/36 patients. FDG-PET alone, CT alone, CT+PET, and FDG-PET/CT showed a sensitivity of 82%, 73%, 91%, and 96%, respectively. Specificities were 79%, 71%, 79%, and 100%, respectively. FDG-PET/CT significantly improved specificity compared with CT+PET and resulted in a further treatment modification in 5/36 patients (14%). CT alone was especially sensitive for lung metastases, FDG-PET alone for the remainder of the body. Accurate fusion of functional and morphologic data by FDG-PET/CT improves the staging accuracy of patients with suspected recurrence of iodine-negative DTC. This has an impact on patient management in a substantial number of patients.

摘要

评估了联合使用2-[18F]氟-2-脱氧-D-葡萄糖正电子发射断层扫描和计算机断层扫描(FDG-PET/CT)对碘阴性分化型甲状腺癌(DTC)患者疑似复发灶的定位作用。36例DTC且疑似碘阴性复发的患者接受了FDG-PET/CT重新分期。CT、FDG-PET、两种模式并排观察(CT+PET)以及FDG-PET/CT的图像由两名医生分别评估。成像结果与组织学(n = 20)和/或至少36个月的临床随访结果相关。36例患者中有22例被诊断为复发疾病。单独的FDG-PET、单独的CT、CT+PET以及FDG-PET/CT的敏感性分别为82%、73%、91%和96%。特异性分别为79%、71%、79%和100%。与CT+PET相比,FDG-PET/CT显著提高了特异性,并导致36例患者中有5例(14%)的进一步治疗方案改变。单独的CT对肺转移特别敏感,单独的FDG-PET对身体其他部位敏感。FDG-PET/CT对功能和形态学数据的准确融合提高了碘阴性DTC疑似复发患者的分期准确性。这对相当一部分患者的治疗管理产生了影响。

相似文献

1
Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer.双模态氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在复发性碘阴性分化型甲状腺癌患者随访中的应用
Eur Radiol. 2007 Dec;17(12):3139-47. doi: 10.1007/s00330-007-0682-2. Epub 2007 May 22.
2
Role of F-Choline Positron Emission Tomography/Computed Tomography to Detect Structural Relapse in High-Risk Differentiated Thyroid Cancer Patients.F-胆碱正电子发射断层扫描/计算机断层扫描在检测高危分化型甲状腺癌患者结构复发中的作用。
Thyroid. 2019 Apr;29(4):549-556. doi: 10.1089/thy.2018.0552.
3
Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?使用[18F]氟代脱氧葡萄糖的重组人促甲状腺激素刺激正电子发射断层扫描是否能提高低血清甲状腺球蛋白患者分化型甲状腺癌复发的检出率?
Thyroid. 2010 Jan;20(1):15-23. doi: 10.1089/thy.2008.0416.
4
Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging F-FDG PET/CT.通过重新分期的F-FDG PET/CT评估分化型甲状腺癌、甲状腺球蛋白升高且I-131全身扫描阴性患者复发的危险因素及分层
Hell J Nucl Med. 2016 Sep-Dec;19(3):208-217. doi: 10.1967/s002449910402. Epub 2016 Nov 8.
5
Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer.MRI与18F FDG PET-CT对甲状腺球蛋白阳性、131I阴性的局部复发或转移性甲状腺癌术后患者的诊断能力
Curr Med Imaging Rev. 2019;15(10):956-964. doi: 10.2174/1573405614666180718124739.
6
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.18F-FDG PET/CT在疑似复发性或转移性高分化甲状腺癌患者中的应用
J Nucl Med. 2007 Feb;48(2):221-6.
7
Initial [18F]FDG PET/CT in high-risk DTC patients. A three-year follow-up.高危分化型甲状腺癌患者的初始[18F]氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描。三年随访
Nuklearmedizin. 2016 Jun 28;55(3):99-103. doi: 10.3413/Nukmed-0766-15-09. Epub 2016 Feb 2.
8
Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET.血清甲状腺球蛋白升高且颈部超声检查阴性的甲状腺癌患者的代谢与形态学联合成像:¹²⁴I-PET/CT和FDG-PET的作用
Eur J Nucl Med Mol Imaging. 2008 May;35(5):950-7. doi: 10.1007/s00259-007-0634-8. Epub 2008 Jan 12.
9
18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.18F-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在疑似复发性甲状腺乳头状癌中的应用:桑尼布鲁克健康科学中心的早期经验
J Otolaryngol Head Neck Surg. 2008 Oct;37(5):712-7.
10
Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.[18F]氟脱氧葡萄糖正电子发射断层扫描在放射性碘阴性复发性高分化甲状腺癌患者中的术前诊断价值
Ann Surg. 2001 Dec;234(6):804-11. doi: 10.1097/00000658-200112000-00012.

引用本文的文献

1
Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid Cancer.分化型甲状腺癌患者18F-FDG PET/CT检查中专用头颈采集的增量价值
PLoS One. 2016 Sep 6;11(9):e0162482. doi: 10.1371/journal.pone.0162482. eCollection 2016.
2
F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis.F18-FDG-PET用于复发性分化型甲状腺癌:一项系统的Meta分析。
Acta Radiol. 2016 Oct;57(10):1193-200. doi: 10.1177/0284185115594645. Epub 2015 Jul 9.
3
Practice trends in patients with persistent detectable thyroglobulin and negative diagnostic radioiodine whole body scans: a survey of American Thyroid Association members.

本文引用的文献

1
Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.骨转移瘤筛查:使用32通道系统的全身MRI与双模态PET-CT的比较
Eur Radiol. 2007 Apr;17(4):939-49. doi: 10.1007/s00330-006-0361-8. Epub 2006 Sep 2.
2
Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer.18F-FDG-PET及PET/CT成像在甲状腺癌中的作用
Biomed Pharmacother. 2006 Sep;60(8):409-13. doi: 10.1016/j.biopha.2006.07.008. Epub 2006 Aug 1.
3
Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management.
持续性可检测到甲状腺球蛋白且诊断性放射性碘全身扫描阴性患者的诊疗趋势:美国甲状腺协会成员调查
Thyroid. 2014 Oct;24(10):1501-7. doi: 10.1089/thy.2014.0043. Epub 2014 Sep 5.
4
Therapeutic impact of (18)F-FDG PET/CT in recurrent differentiated thyroid carcinoma.(18)F-FDG PET/CT 在复发性分化型甲状腺癌中的治疗作用。
Radiol Med. 2014 Feb;119(2):97-102. doi: 10.1007/s11547-013-0323-6. Epub 2013 Nov 26.
5
Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma.甲状腺球蛋白水平和甲状腺球蛋白倍增时间可独立预测分化型甲状腺癌患者生化复发后 18F-FDG PET/CT 扫描阳性。
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):874-80. doi: 10.1007/s00259-013-2370-6. Epub 2013 Mar 6.
6
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma.提高分化型甲状腺癌患者甲状腺刺激激素刺激的 2-(18-氟)-flu-2-脱氧-D-葡萄糖正电子发射断层扫描-CT 的产量。
Br J Radiol. 2012 Oct;85(1018):e805-13. doi: 10.1259/bjr/26733491.
7
Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for localizing recurrence in patients with differentiated thyroid carcinoma.(124)I-PET/CT 和(18)F-FDG-PET/CT 对分化型甲状腺癌患者局部复发的定位效果。
J Korean Med Sci. 2012 Sep;27(9):1019-26. doi: 10.3346/jkms.2012.27.9.1019. Epub 2012 Aug 22.
8
Comparison of diagnostic and prognostic capabilities of ¹⁸F-FDG-PET/CT, ¹³¹I-scintigraphy, and diffusion-weighted magnetic resonance imaging for postoperative thyroid cancer.¹⁸F-FDG-PET/CT、¹³¹I 闪烁扫描和扩散加权磁共振成像在甲状腺癌术后诊断和预后能力的比较。
Jpn J Radiol. 2011 Jul;29(6):413-22. doi: 10.1007/s11604-011-0572-z. Epub 2011 Jul 24.
9
SPECT/CT imaging in children with papillary thyroid carcinoma.SPECT/CT 显像在儿童甲状腺乳头状癌中的应用。
Pediatr Radiol. 2011 Aug;41(8):1008-12. doi: 10.1007/s00247-011-2039-x. Epub 2011 May 24.
10
Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.肿瘤学中的分子影像学:PET/CT 的接受和 MR/PET 成像的出现。
Eur Radiol. 2011 Mar;21(3):548-54. doi: 10.1007/s00330-010-2033-y. Epub 2010 Dec 21.
集成式PET/CT在分化型甲状腺癌中的应用:诊断准确性及对患者管理的影响
J Nucl Med. 2006 Apr;47(4):616-24.
4
Thyroid-stimulating hormone-stimulated fused positron emission tomography/computed tomography in the evaluation of recurrence in 131I-negative papillary thyroid carcinoma.促甲状腺激素刺激下的融合正电子发射断层扫描/计算机断层扫描在评估¹³¹I阴性甲状腺乳头状癌复发中的应用
Thyroid. 2006 Mar;16(3):267-72. doi: 10.1089/thy.2006.16.267.
5
The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature.18F-氟代脱氧葡萄糖正电子发射断层扫描在分化型甲状腺癌随访中的价值:文献综述
Q J Nucl Med Mol Imaging. 2006 Mar;50(1):78-87.
6
False-positive FDG PET uptake--the role of PET/CT.氟代脱氧葡萄糖正电子发射断层显像(FDG PET)假阳性摄取——PET/CT的作用
Eur Radiol. 2006 May;16(5):1054-65. doi: 10.1007/s00330-005-0088-y. Epub 2005 Dec 17.
7
Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma.甲状腺乳头状癌患者转移性淋巴结与良性淋巴结的超声鉴别
J Ultrasound Med. 2005 Oct;24(10):1385-9. doi: 10.7863/jum.2005.24.10.1385.
8
Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.氟-18-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在血清甲状腺球蛋白升高但碘-131全身扫描阴性的甲状腺癌患者中的初步应用经验。
Singapore Med J. 2005 Jun;46(6):297-301.
9
Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results.双模态PET/CT检测肝转移瘤射频消融术后残余肿瘤:初步结果
Eur Radiol. 2006 Jan;16(1):80-7. doi: 10.1007/s00330-005-2767-0. Epub 2005 May 3.
10
Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在原发灶不明的宫颈癌患者中的双重模式
Med Princ Pract. 2005 May-Jun;14(3):155-60. doi: 10.1159/000084632.